Shortly before the trial was set to begin this morning, the drugmaker agreed to end the Deutsch case by making an undisclosed payment. The case “has been resolved to the mutual satisfaction of the parties. The terms of the resolution and events leading up to it are confidential and sealed, so we won’t be able to provide any further comment on this case,” according to an e-mail from Wyeth spokesman Chris Garland.

Ellen Deutsch, who took the hormone replacement therapy – and its predecessor, Premarin – for a total of seven years and was eventually diagnosed with breast cancer. Deutsch, who lives in Livingston, NJ, a New York suburb, was 55 at the time she was diagnosed.

As with the handful of previous cases, which have resulted in a mixed bag for Wyeth, Deutsch’s lawyers charged that the drugmaker spent decades actively promoting hormone replacement therapy as a desirable, life-long menopausal treatment, but failed to sufficiently study the medcation and, later, backpedaled on its claims before a government-funded study linked the drugs to cancer and heart risks.

Previous Prempro cases took place in Pennsylvania state court in Philadelphia and federal court in Little Rock, Arkansas.

 



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Highly recommended

I would highly recommend this law firm to handle any of your legal needs.

—Sandy